BRAF variant allele fraction-A predictor of response to targeted therapy?
J Eur Acad Dermatol Venereol
.
2023 Oct;37(10):1945-1946.
doi: 10.1111/jdv.19389.
Authors
Mitchell S Stark
1
,
Teresa Harris
1
,
Douglas Grossman
2
3
4
,
Robert Judson-Torres
2
3
4
Affiliations
1
Frazer Institute, Dermatology Research Centre, The University of Queensland, Brisbane, Queensland, Australia.
2
Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
3
Department of Oncological Sciences, School of Medicine, University of Utah, Salt Lake City, Utah, USA.
4
Department of Dermatology, School of Medicine, University of Utah, Salt Lake City, Utah, USA.
PMID:
37746754
DOI:
10.1111/jdv.19389
No abstract available
Publication types
Comment
MeSH terms
Alleles
Humans
Proto-Oncogene Proteins B-raf* / genetics
Substances
Proto-Oncogene Proteins B-raf
BRAF protein, human